The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
6-{[4-(1,4-dimethylpiperidin-4-yl)phenyl]amino}-1-[6-(2-hydroxypropan-2-yl)pyridin-2-yl]-2-(prop-2-en-1-yl)-1H,2H,3H-pyrazolo[3,4-d]pyrimidin-3-one ID: ALA5280668
Max Phase: Preclinical
Molecular Formula: C29H35N7O2
Molecular Weight: 513.65
Associated Items:
Names and Identifiers Canonical SMILES: C=CCn1c(=O)c2cnc(Nc3ccc(C4(C)CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1
Standard InChI: InChI=1S/C29H35N7O2/c1-6-16-35-26(37)22-19-30-27(33-25(22)36(35)24-9-7-8-23(32-24)28(2,3)38)31-21-12-10-20(11-13-21)29(4)14-17-34(5)18-15-29/h6-13,19,38H,1,14-18H2,2-5H3,(H,30,31,33)
Standard InChI Key: YFIFDFGPNQFIOE-UHFFFAOYSA-N
Molfile:
RDKit 2D
38 42 0 0 0 0 0 0 0 0999 V2000
4.6395 -1.9207 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8336 -1.7444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2767 -2.3591 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4708 -2.1828 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2159 -1.3981 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7727 -0.7834 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5843 -0.9535 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5177 0.0012 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.0061 0.6733 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5177 1.3454 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7275 1.0888 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7275 0.2579 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0114 -0.1516 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.2953 0.2591 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2953 1.0888 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.0114 1.5079 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4185 -0.1544 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.1335 0.2570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8499 -0.1606 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5711 0.2507 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5711 1.0757 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8546 1.4935 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1335 1.0863 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2879 1.4841 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7727 2.1300 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.8311 0.6733 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2436 1.3855 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0728 1.3855 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1953 -1.3107 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8531 -2.7178 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4366 -2.1343 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.0001 1.0674 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.7172 1.4759 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.7220 2.3011 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.0097 2.7178 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2926 2.3093 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.4366 2.7138 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7043 2.0676 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
3 2 2 0
4 3 1 0
5 4 2 0
6 5 1 0
7 6 2 0
7 2 1 0
6 8 1 0
9 8 1 0
9 10 1 0
10 11 1 0
12 11 1 0
8 12 1 0
13 12 2 0
14 13 1 0
15 14 2 0
11 16 2 0
15 16 1 0
17 14 1 0
18 17 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
18 23 1 0
24 21 1 0
10 25 2 0
26 9 1 0
26 27 1 0
27 28 2 0
1 29 1 0
1 30 1 0
1 31 1 0
32 24 1 0
33 32 1 0
34 33 1 0
35 34 1 0
36 35 1 0
24 36 1 0
34 37 1 0
24 38 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 513.65Molecular Weight (Monoisotopic): 513.2852AlogP: 4.12#Rotatable Bonds: 7Polar Surface Area: 101.10Molecular Species: BASEHBA: 9HBD: 2#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: 12.86CX Basic pKa: 9.32CX LogP: 3.92CX LogD: 2.00Aromatic Rings: 4Heavy Atoms: 38QED Weighted: 0.36Np Likeness Score: -0.69
References 1. Guler S, DiPoto MC, Crespo A, Caldwell R, Doerfel B, Grossmann N, Ho K, Huck B, Jones CC, Lan R, Musil D, Potnick J, Schilke H, Sherer B, Simon S, Sirrenberg C, Zhang Z, Liu-Bujalski L.. (2023) Selective Wee1 Inhibitors Led to Antitumor Activity In Vitro and Correlated with Myelosuppression., 14 (5): [PMID:37197456 ] [10.1021/acsmedchemlett.2c00481 ]